lncRNAs or miRNAs could be manipulated by small interfering RNAs, antisense RNAs, RNA mimics, or CRISPR/Cas9 carried by nanoparticle-based delivery systems
We cannot ship treatments outside of these provinces at this time
No claims are made regarding safety, efficacy, or suitability for any purpose outside controlled research settings
Insulin resistance and hyperinsulinaemia in the development and progression of cancer
PT-141 Side Effects At the recommended dose of 1.75 mg, bremelanotide may produce the following common side effects [2]: Nausea (40% particularly with the first injection) Flushing (20%) Injection site reactions (13%) Headaches (11%) Uncommon adverse reactions include [2]: Increases in blood pressure Severe nausea Vomiting Arthralgia Restless leg syndrome Local hyperpigmentation Due to the risk of the peptide causing an increase in blood pressure and reduction in heart rate, it should not be administered to subjects who are [16]: Pregnant or suspected of being pregnant Suffering from cardiovascular disease Diagnosed with uncontrolled hypertension In rare instances, PT-141 may lead to elevated serum enzyme levels, and in even rarer cases, cause acute liver damage [2]
For example, studies have shown that participants taking tirzepatide (available as Mounjaro and Zepbound, or through our Compounded Tirzepatide and Oral Tirzepatide programs) can experience substantial body weight reductions, often exceeding 15-20% over prolonged treatment periods, which is more significant than with GLP-1 monotherapy alone
